Check the effect of devdar tail in the treatment of dushta vran.

A standard control clinical trial of devdar tail in the management of dushta vrana.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017273

Enrollment

Registered

2019-01-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Devdar taila: cedrus wood oil Intervention2: Cedrus wood oil (Devdar taila): Drug- Devdar taila Route of administration-local application Frequency - daily aaplication Duration of stud

Eligibility

Inclusion criteria

Inclusion criteria: Non healing wound. Age of patient between 20 yrs to 40 yrs. Patient will be selected with dushtavrana irrespective of gender & religion. Dushta Vrana within size of >=2 Ã? 2 cm upto 5 x 5 cm(Length x Breadth). History of wound 2 weeks- 12 weeks TLC count Infected wound without h/o systemic wound manifistation.

Exclusion criteria

Exclusion criteria: Known cases of Malignant wounds, anemia, leprosy, sephalis. Diagnosed T.B Patients. Known cases of D.M (diabetic wound). Dagdha Vrana / Burns. Gangrenous wound. Septicemia. Arterial and venous ulcers (peripheral vascular diseases).

Design outcomes

Secondary

Measure	Time frame
wound healing slow than povidone iodine (control drug)Timepoint: wound is not healing in 15 days	—

Primary

Measure	Time frame
wound healing fast than povidone iodine (control drug)Timepoint: wound healing fast in 15 Days	—

Countries

India

Contacts

Public ContactGanesh Budhaji Bendhari

Collage of Ayurved and research center, Nigadi, Pune.

drbharat_oza@yahoo.co.in9970254593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026